Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database
Pal Moller, Toni T Seppala, Inge Bernstein, Elke Holinski-Feder, Paulo Sala, D Gareth Evans, Annika Lindblom, Finlay Macrae, Ignacio Blanco, Rolf H Sijmons, Jacqueline Jeffries, Hans FA Vasen, John Burn, Sigve Nakken, Eivind Hovig, Einar Andreas Rodland, Kukatharmini Tharmaratnam, Wouter H de Vos Tot Nederveen Cappel, James Hill, Juul T Wijnen Show all
GUT | BMJ PUBLISHING GROUP | Published : 2018
Awarded by FEDER funds- a way to build Europe
Awarded by RTICC
Awarded by Government of Catalonia
This work was supported by The Finnish Cancer Foundation; The Sigrid Juselius Foundation; The Finnish Medical Foundation; Jane and Aatos Erkko Foundation; Finnish State Research Funding; the Swedish Cancer Society; the Swedish Research Council; the Stockholm Cancer Society; the Norwegian Radium Hospital Foundation; the Wales Gene Park funded by Health and Care Research Wales; and the Spanish Ministry of Economy and Competitiveness and co-funded by FEDER funds- a way to build Europe- (SAF2012-33636 and SAF2015-68016); the Carlos III Health Institute; RTICC (RD12/0036/0031); the Scientific Foundation Asociacion Espanola Contra el Cancer; and the Government of Catalonia (2014 SGR 338). D Gareth Evans is an NIHR senior investigator. Mark Jenkins has a fellowship from the National Health and Medical Research Council of Australia.